IRIS Accounts Production v24.1.4.33 09905241 Board of Directors 1.1.23 31.12.23 31.12.23 0 0 false true false false true false Ordinary 2.50000 4338 4338 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099052412022-12-31099052412023-12-31099052412023-01-012023-12-31099052412021-12-31099052412022-01-012022-12-31099052412022-12-3109905241ns15:EnglandWales2023-01-012023-12-3109905241ns14:PoundSterling2023-01-012023-12-3109905241ns10:Director12023-01-012023-12-3109905241ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3109905241ns10:SmallEntities2023-01-012023-12-3109905241ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3109905241ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3109905241ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3109905241ns10:FullAccounts2023-01-012023-12-3109905241ns10:OrdinaryShareClass12023-01-012023-12-310990524142ns10:Director22021-12-310990524142ns10:Director22022-01-012022-12-3109905241ns10:Director22023-01-012023-12-3109905241ns10:CompanySecretary12023-01-012023-12-3109905241ns10:RegisteredOffice2023-01-012023-12-3109905241ns5:CurrentFinancialInstruments2023-12-3109905241ns5:CurrentFinancialInstruments2022-12-3109905241ns5:ShareCapital2023-12-3109905241ns5:ShareCapital2022-12-3109905241ns5:RetainedEarningsAccumulatedLosses2023-12-3109905241ns5:RetainedEarningsAccumulatedLosses2022-12-3109905241ns5:PlantMachinery2023-01-012023-12-3109905241ns5:ComputerEquipment2023-01-012023-12-3109905241ns5:PlantMachinery2022-12-3109905241ns5:PlantMachinery2023-12-3109905241ns5:PlantMachinery2022-12-3109905241ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3109905241ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3109905241ns10:OrdinaryShareClass12023-12-31099052411ns10:Director12022-12-31099052411ns10:Director12021-12-31099052411ns10:Director12023-01-012023-12-31099052411ns10:Director12022-01-012022-12-31099052411ns10:Director12023-12-31099052411ns10:Director12022-12-31
REGISTERED NUMBER: 09905241 (England and Wales)














FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

JDR MEDICAL LIMITED

JDR MEDICAL LIMITED (REGISTERED NUMBER: 09905241)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


JDR MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTORS: L Carr
P Bush





SECRETARY: L Carr





REGISTERED OFFICE: 12 Dunholme Close
Aykley Heads
Durham
DH1 5WB





REGISTERED NUMBER: 09905241 (England and Wales)





ACCOUNTANTS: RMT Ribchesters
Accountants and Business Advisors
Finchale House
Belmont Business Park
Durham
DH1 1TW

JDR MEDICAL LIMITED (REGISTERED NUMBER: 09905241)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 56 419

CURRENT ASSETS
Debtors 5 22,450 1,987
Cash at bank 405,922 204,289
428,372 206,276
CREDITORS
Amounts falling due within one year 6 63,301 14,787
NET CURRENT ASSETS 365,071 191,489
TOTAL ASSETS LESS CURRENT
LIABILITIES

365,127

191,908

PROVISIONS FOR LIABILITIES 14 105
NET ASSETS 365,113 191,803

CAPITAL AND RESERVES
Called up share capital 7 1 1
Retained earnings 365,112 191,802
SHAREHOLDERS' FUNDS 365,113 191,803

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

JDR MEDICAL LIMITED (REGISTERED NUMBER: 09905241)

BALANCE SHEET - continued
31 DECEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 September 2024 and were signed on its behalf by:





P Bush - Director


JDR MEDICAL LIMITED (REGISTERED NUMBER: 09905241)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1. STATUTORY INFORMATION

JDR Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover derives from the principal activity of the company, which is that of the provision of anaesthetic services.

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes and is recognised when the company becomes entitled to it.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Assessment equipment - 33% on cost
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

JDR MEDICAL LIMITED (REGISTERED NUMBER: 09905241)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2023
and 31 December 2023 4,552
DEPRECIATION
At 1 January 2023 4,133
Charge for year 363
At 31 December 2023 4,496
NET BOOK VALUE
At 31 December 2023 56
At 31 December 2022 419

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 22,450 -
Other debtors - 1,987
22,450 1,987

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 53,091 9,943
Other creditors 10,210 4,844
63,301 14,787

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
40 Ordinary 2.5p 1 1

JDR MEDICAL LIMITED (REGISTERED NUMBER: 09905241)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2023 and 31 December 2022:

2023 2022
£    £   
P Bush and L Carr
Balance outstanding at start of year - 4,338
Amounts repaid - (4,338 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -

9. RELATED PARTY DISCLOSURES

During the year the directors provided an interest free loan to the company. At 31 December 2023 the balance on the loan was £7,992. (2022:£2,506)

Included within trade debtors is an amount due from a company whose director is also a director of this company. At the balance sheet date the amount outstanding was £22,450.